Home  >  News
News
  Quest completes acquisition of Shiel Medical Laboratory from Fresenius Medical Care,   December 14, 2017
  US FDA extends action date for Pfizer's sNDA for Xeljanz in ulcerative colitis,   December 14, 2017
  Allergan's CoolSculpting treatment receives US FDA nod to improve appearance of lax tissue in double chin,   December 14, 2017
  NeuroVive’s KL1333 programme receives European orphan drug designation,   December 14, 2017
  UK MHRA grants PIM designation to Prometic's orally-active drug candidate, PBI-4050 to treat idiopathic pulmonary fibrosis,   December 13, 2017
  Ionis Pharma licenses IONIS-HTT Rx to Roche following successful phase 1/2a study in patients with Huntington's disease,   December 13, 2017
  Tetraphase selects Novasep to manufacture eravacycline API,   December 13, 2017
  Bayer´s partner, Janssen seeks US FDA approval for rivaroxaban to treat coronary and/or peripheral artery disease,   December 13, 2017
  US FDA accepts Regeneron's sBLA filing for 12-week dosing of Eylea injection for patients with wet AMD,   December 13, 2017
  Eli Lilly's galcanezumab BLA for prevention of migraine in adults accepted by US FDA for review,   December 13, 2017
  US FDA accepts Merck's sBLA filing for Keytruda to treat relapsed/refractory PMBCL,   December 13, 2017
  Sanofi’s Admelog receives US FDA approval to manage blood sugar levels at mealtime,   December 12, 2017
  MeiraGTx's gene therapy product candidate A001 gets US FDA rare pediatric disease designation to treat Leber’s Congenital Amaurosis,   December 09, 2017
  EMA committee recommends orphan drug designation for Sangamo's genome editing treatments for MPS I & MPS II,   December 09, 2017
  Ortho, Sphingotec ink strategic agreement on novel biomarker for decreasing re-hospitalizations in heart failure,   December 09, 2017
  US FDA advances new digital health policies to encourage innovation, efficiency & modernization to regulation,   December 09, 2017
  Gilead Sciences to acquire biotherapeutics company Cell Design Labs for $567 million,   December 08, 2017
  Edwards Lifesciences acquires medical technology company, Harpoon Medical for $100 million,   December 08, 2017
  Bristol-Myers announces US FDA lifts partial clinical holds on two opdivo-based combo studies in multiple myeloma,   December 07, 2017
  Sonoma Pharma gets US FDA approval to add antimicrobial language to alevicyn gel products for management of atopic dermatitis,   December 07, 2017

 Back
 
PITS_2017
duphat_150x60
Pre-Connect Congress 2017
acssymposium
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |